Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods of dosing propofol prodrugs for inducing mild to moderate levels of sedation

A mild, sedative technology, used in pharmaceutical formulations, drug combinations, medical preparations containing active ingredients, etc., can solve problems such as hindering development and poor bioavailability of propofol

Inactive Publication Date: 2008-08-20
EISAI INC
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the poor bioavailability of propofol when administered by any non-intravenous route hinders the development of this treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of dosing propofol prodrugs for inducing mild to moderate levels of sedation
  • Methods of dosing propofol prodrugs for inducing mild to moderate levels of sedation
  • Methods of dosing propofol prodrugs for inducing mild to moderate levels of sedation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1A

[0053] In this example, 93 patients were administered the fentanyl and bolus propofol prodrug doses as summarized in Table 2 below.

[0054] Table 2

[0055] Propofol prodrug rapid injection dose group

[0056] 7.5 mg /

kilogram

10mg / thousand

gram

12.5 mg /

kilogram

Total

Fentanyl

Quantitative

medicine

0.5 μg / kg

4

13

10

27

1.0 μg / kg

9

14

11

34

1.5 μg / kg

11*

10

11

32

Total

24

37

32

93

[0057] *One patient received 1.5 μg / kg fentanyl + 8.5 μg / kg bolus dose of propofol prodrug

[0058] Demographics of patients in Example 1A summarized by original assignment to treatment groups (mg / kg) in Table 3.

[0059] Table 3 Demographic and other baseline characteristics of treatment groups (Example 1A)

[0060] Rapid Injection Do...

Embodiment 1B

[0070] In this example, the initial dosing regimen was divided into 2 individual reconstitutions, each with fixed fentanyl and propofol prodrug doses. Some initial patients weighed 75 to 80 kg and were dosed with 980 mg (28 mL). During this initial portion, subjects became increasingly sedated (MOAA / S75 to >80 kg. Table 5 summarizes the adjusted weight-based fixed dosing regimen.

[0071] Table 5 Weight-Based Fixed Dosing Regimen

[0072] patient weight

Pretreatment Fen

Dosage of tanyl

Initial propofol prodrug rapid

injection dose

Propofol Prodrug Supplement Dosage

18-70 years old

≤50kg

50 micrograms

630 mg (18 mL)

Up to 105 mg (3 mL)

>50kg to ≤65kg

60 micrograms

700mg (20ml)

Up to 140 mg (4 mL)

>65kg to ≤80kg

70 micrograms

805 mg (23 mL)

Up to 175 mg (5 mL)

>80kg

80 micrograms

910 mg (26 mL)

Up to 175 mg (5 mL)

Patients ≥70 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A dosage of a propofol prodrug needed for inducing mild to moderate sedation levels in a patient is calculated based on a patient's lean body mass. It has been discovered dosages based on gross body mass may result in overdosing, particularly for obese patients. In another aspect, a dosage suitable for inducing mild to moderate sedation levels in a patient who is at least 60 years of age is determined. A weight- appropriate dosage for the patient is determined and then adjusted by an age-based factor. For example, the dosage needed to produce a sedated state or other effect in a patient who is 60 years of age or older may be about 0.6 - 0.8 times the dosage needed to produce a corresponding effect in a younger patient of the same weight.

Description

[0001] This application claims priority to US Provisional Application Serial No. 60 / 698,404, filed July 12, 2005, which is hereby incorporated by reference. field of invention Background of the invention [0002] The outpatient setting is becoming more common for various types of medical procedures that require sedation. During outpatient colonoscopy, for example, benzodiazepines are widely used for sedation. The combination of midazolam hydrochloride with a narcotic analgesic is a very common drug regimen used to provide mild to moderate sedation and analgesia. Gastroenterologists have sought alternative treatments, which are used on an outpatient basis, to provide faster recovery times and accelerated "street-fitness" after patient sedation for outpatient surgery and diagnostic procedures. [0003] The use of injectable anesthetics, especially propofol, for the induction and maintenance of general anesthesia has gained general acceptance in anesthesia care over the past 1...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/445
CPCA61K31/661A61K31/445A61P1/08A61P17/04A61P21/02A61P25/06A61P25/08A61P25/10A61P25/12A61P25/20A61P25/28
Inventor E·吉比安斯基L·吉比安斯基
Owner EISAI INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com